Journals / Anadolu Kardiyoloji Dergisi / 2013 / Cilt: 13 - Sayı: 2

Basic principles in liquid electrolyte treatment

Sıvı elektrolit tedavisinde temel prensipler

Pages
171–177
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For every patient presenting unexplained symptoms of the muscular, skeletal, or neurological systems, including confusion, making the first prior- ity the conduction of electrolyte analyses and the correctly managed effective treatment of excesses or deficiencies may save lives and will cer- tainly save time and money that would otherwise have been spent unnecessarily.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Under normal physiological conditions, our body fluids and electrolytes are protected in complete balance in a wonderful, flawless design.
📊
Key Findings & Data:Serum sodium levels of 120, 140, or 150 mEq/L alone should be meaning- less to the physician in relation to total body sodium and water content because either hyponatremia or hypernatremia can occur while the patient is hypovolemic, euvolemic, or hypervolemic.
💡
Conclusion & Impact:For every patient presenting unexplained symptoms of the muscular, skeletal, or neurological systems, including confusion, making the first prior- ity the conduction of electrolyte analyses and the correctly managed effective treatment of excesses or deficiencies may save lives and will cer- tainly save time and money that would otherwise have been spent unnecessarily.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Under normal physiological conditions, our body fluids and electrolytes are protected in complete balance in a wonderful, flawless design. Even small deviations occurring in this equilibrium may lead to impairments, which can end in death. Especially in fairly common sodium metabolism disorders, it is the responsibility of the clinician to determine, according to the patient’s history and her physical examination of him, whether there is an excess or depletion of volume, and to arrange subsequent treatment. Serum sodium levels of 120, 140, or 150 mEq/L alone should be meaning- less to the physician in relation to total body sodium and water content because either hyponatremia or hypernatremia can occur while the patient is hypovolemic, euvolemic, or hypervolemic. For example, administering hypertonic or isotonic saline treatment to a patient with hypervolemic hyponatremia in order to correct the sodium will clinically lead to both an increase in edema and a worsening of the hyponatremia. Treatment of hypo- and hypernatremia must be adjusted separately for each patient based on his age, presence of comorbid conditions, and the speed of devel- opment of the severity of clinical signs and symptoms. Adjustments either executed too slowly or too quickly will increase mortality or morbidity. For every patient presenting unexplained symptoms of the muscular, skeletal, or neurological systems, including confusion, making the first prior- ity the conduction of electrolyte analyses and the correctly managed effective treatment of excesses or deficiencies may save lives and will cer- tainly save time and money that would otherwise have been spent unnecessarily.

Özet

Normal fizyolojik koşullar altında, vücut sıvılarımız ve elektrolitlerimiz muhteşem kusursuz tasarım içinde tam bir dengede korunmaktadırlar. Bu dengede oluşacak olan küçük sapmalar bile sonu ölümle bitebilecek olan önemli bozukluklara yol açabilir. Özellikle oldukça sık görülen sodyum metabolizması bozukluklarında klinisyenin sorumluluğu hastanın fizik muayene ve öyküsü ile hacim kaybı ya da fazlalığının olup olmadığını belirle- mek ve tedaviyi ona göre düzenlemektir. 120 mEq/L, 140 mEq/L, 150 mEq/L düzeylerindeki serum sodyum ölçümleri tek başına toplam beden sodyum ve su içeriği hakkında hekime hiçbir şey ifade etmemelidir. Çünkü hem hiponatremi, hem hipernatremi hasta klinik olarak hipovolemik, övolemik ve hipervolemik iken oluşabilir. Örneğin, hipervolemik hiponatremisi olan bir hastaya, sodyumu düzeltmek amacıyla hipertonik ya da izotonik NaCl tedavisinin verilmesi, klinik olarak hem ödemin artışına, hem de hiponatreminin ağırlaşmasına yol açacaktır. Hipo ve hipernatremide tedavi, hasta- nın yaşına, eşlik eden hastalıkların varlığına, klinik belirti ve bulguların şiddeti ile gelişme hızına göre her hasta için ayrı düzenlenmelidir. Hem aşırı yavaş, hem de aşırı hızlı yapılacak olan düzeltmeler mortalite ve morbiditeyi arttırırlar. Bilinç bulanıklığı dahil açıklanamayan, nörolojik, kas, iskelet sistemi bulguları olan her hastada, öncelikli olarak elektrolit analizlerinin yapılması, eksiklik ya da fazlalıklarının doğru yönetimle etkin bir şekilde tedavi edilmesi yaşam kurtarıcı olabileceği gibi, gereksiz daha pahalı tetkiklerin yapılmasını ve zaman kaybını engelleyecektir.

🔖

Cite This Article

ZÜMRÜTDAL, A. (2022). Basic principles in liquid electrolyte treatment. Anadolu Kardiyoloji Dergisi, Cilt: 13 - Sayı: 2, 171–177. https://ajindex.com/articles/436618

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Smith H. From fish to philosopher: the story of our internal environment. Boston: Little, Brown; 1953
  2. Strens RH. Maintenance and replacement fluid therapy in adults. Available at: URL: www.uptodate.com, version 7, 2012
  3. Berger BE. Hyponatremia and hypernatremia. In Hricik DE, Miller RT, Sedor JR, editors. Nephrology Secrets. 2nd ed. Hanley and Belfus: Inc; 2004.p.279-87
  4. Berl T, Schrier RW. Su metabolizma bozuklukları. In: Schrier RW, editor. Süleymanlar G çev. editör. Böbrek ve elektrolit hastalıkları. 6th ed. Lippincott Williams&Wilkins: Güneş Kitabevi; Ankara 2005. p.1-63. (translated
  5. Ostermann M, Alvarez G, Sharpe MD, Martin CM. Frusemide administration in critically ill patients by continuous compared to bolus therapy. Nephron Clin Pract 2007; 107: 70-6. [CrossRef] 6. Allen LA, Turer AT, Dewald T, Stough WG, Cotter G, O'Connor CM. Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure. Am J Cardiol 2010; 105: 1794-7. [CrossRef] 7. Dormans TP van Meyel JJ, Gerlag PG, Tan Y, Russel FG, Smits P Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol 1996; 28: 376-82. [CrossRef] 8. Weinfeld MS, Chertow GM, Stevenson LW. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 1999; 138: 285-90. [CrossRef] 9. Belziti CA, Bagnati R, Ledesma P Vulcano N, Fernández S. Worsening renal function in patients admitted with acute decompensated heart failure: incidence, risk factors and prognostic implications. Rev Esp Cardiol 2010; 63: 294-302. [CrossRef] 10. Mullens W, Abrahams Z, Francis GS, Taylor DO, Starling RC, Tang WH. Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Card Fail 2008; 14: 508-14. [CrossRef] 11. Kazory A, Ross EA. Ultrafiltration for decompensated heart failure: renal implications. Heart 2009; 95: 1047-51. [CrossRef] 12. Kamath SA. The role of ultrafiltration in patients with decompensated heart failure. Int J Nephrol 2010; 2011: 190230
  6. Nolph KD, Schrier RW. Sodium, potassium and water metabolism in the syndrome of inappropriate antidiuretic hormone secretion. Am J Med 1970; 49: 534-45. [CrossRef] 14. Narayen G, Mandal SN. Vasopressin receptor antagonists and their role in clinical medicine. Indian J Endocrinol Metab 2012; 16: 183-91. [CrossRef] 15. Cassagnol